2m 2m 2m 2m 2m 2m 2m
IMMUNIC (IMUX)
NASDAQ
$14.70+$0.06 (+0.41%)
Price as of Jul 14, 2026 10:12 AM EDT- $199.4MMarket Cap
- 74.29%1-Year Change
- BiotechnologyIndustry
IMMUNIC (IMUX)
$14.70+$0.06 (+0.41%)
IMUX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.64 | ||
Change | -$0.13 (-0.88%) | ||
Open | $14.74 | ||
High | $14.87 | ||
Low | $14.19 | ||
Previous Close | $14.77 | ||
Volume | 251,918 | ||
30-Day Average Volume | 184,647 | ||
1-Week Change | -1.48% | ||
1-Month Change | 5.63% | ||
1-Year Change | 74.29% | ||
3-Year Change | -46.18% | ||
5-Year Change | -88.12% | ||
Fundamentals | |||
Shares Outstanding | 13.6M | ||
Total Assets | $189.7M | ||
Market Cap | $199.4M | ||
Enterprise Value | $12.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.6M | ||
Free Cash Flow | -$17.3M | ||
EBIT | -$32.6M | ||
EBITDA | -$32.6M | ||
Net Working Capital | $150.4M | ||
EPS | -$10.80 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/27/2026 | ||
Earnings & Revenue